This site is secured using RapidSSL
An image from our site
An image from our site Colorectal Cancer
Colorectal Cancer, also known as bowel cancer, develops in the colon or the rectum (the large bowel or the large intestine)...
An image from our site Gastric Cancer
Stomach cancer, also known as gastric cancer, is a cancer which develops from the lining of the stomach...
An image from our site Pancreatic Cancer
Pancreatic cancer is caused by malignant (cancer) cells that form in the tissues of the pancreas...
An image from our site Rare Cancers
Rare cancers are classified in the group of rare diseases which are defined in the EU as diseases with a prevalence of less than 5 cases out of a population of 10,000...




About Us

DiCE is the voice of digestive cancer patients in Europe. Its aim is to save lives by bringing together all key stakeholders in the fight against these cancers.

Digestive Cancers Europe is founded as a Belgian non-profit organisation by Jola Gore-Booth - founder of EuropaColon, Prof. Dr. Eric Van Cutsem - Digestive Oncologist at the University Hospital of Leuven, Belgium and Stefan Gijssels - colon cancer patient and health policy expert. Since its foundation in 2004, EuropaColon has gradually expanded geographically now representing 40 patient organisations in 30 countries. Jola Gore-Booth, founder of EuropaColon explains:

“Over the last 14 years we have set up alliances with existing patient organisations or set up new patient advocacy groups to make sure that the voice of the patient is heard in every European country. We cover almost all countries now and it’s the right time to also include other digestive cancer patients whose voice was not represented so far”.

The number of patients dying from digestive cancers is excessively high. More than 800,000 people in Europe get diagnosed every year with one of the digestive cancer types and approximately 500,000 patients die every year.

Colorectal cancer is highly preventable and when detected early, overall survival rates are approximately 90%. Unfortunately only 16% of patients get diagnosed at an early stage which demonstrates the strong importance of formal population-based screening programmes.

With the best possible screening 380,000 extra lives could be saved annually and 14 billion Euro saved.

The priority activity is to increase overall survival and save an extra 250,000 lives per year by 2028.

Latest News

This is an image from this news item. (click to visit)
This is an image from this news item. (click to visit)
This is an image from this news item. (click to visit)
This is an image from this news item. (click to visit)
This is an image from this news item. (click to visit)
Study Identifies 40 New Genetic Variants
PASYKAF Cyrpus wins ImpactPANC Award!
Screening for CRC may benefit male patients
Want to keep bowel cancer risk at bay?
Your 'Second Brain' is in your gut
An image from our site
Digestive Cancers Europe
Scots House
Scots Lane
Salisbury
SP1 3TR
United Kingdom
Tel: +44 1722 333 587
info@digestivecancers.eu


Youtube Facebook Facebook
Warning!!! Warning!!! Cookies are disabled Warning!!! Warning!!!